ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 227 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,201,494 | +2.9% | 633,469 | +18.3% | 0.07% | +7.8% |
| Q2 2023 | $12,827,165 | +36.8% | 535,581 | +7.5% | 0.06% | +25.5% |
| Q1 2023 | $9,375,710 | +20.3% | 498,178 | +1.8% | 0.05% | +13.3% |
| Q4 2022 | $7,793,572 | -6.6% | 489,546 | -4.0% | 0.04% | -18.2% |
| Q3 2022 | $8,342,000 | +290.7% | 509,921 | +236.5% | 0.06% | +323.1% |
| Q2 2022 | $2,135,000 | +52.9% | 151,516 | +162.9% | 0.01% | +85.7% |
| Q1 2022 | $1,396,000 | -18.6% | 57,635 | -48.7% | 0.01% | -30.0% |
| Q2 2018 | $1,715,000 | +419.7% | 112,325 | +980.0% | 0.01% | +233.3% |
| Q4 2014 | $330,000 | – | 10,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |